Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : The Big Tex House of Coin -- Ignore unavailable to you. Want to Upgrade?

To: BigTex who wrote (8894)	11/17/1999 2:42:00 PM
From: Spark	Respond to of 19297

RMGG..China play still at the bottom.. Rocky Mountain Ginseng, Inc. Retains Seasoned Merger and Acquisitions Veteran to Spearhead Accelerated Growth Plan Acquisition Plan Targets Nutritional Supplement Internet Market VANCOUVER, British Columbia--(BUSINESS WIRE)--Nov. 8, 1999-- Robert Bell, President of Rocky Mountain Ginseng, Inc. (OTCBB:RMGG - news), announced today that the company has retained Jerry G. Simek as a financial consultant. Simek has been President of the JGS Management Group since 1984. Simek specializes in strategic planning, financial management, business/corporate development and mergers & acquisitions. He has successfully directed and implemented several corporate reorganizations, financing, acquisition and divestiture programs in the U.S. and Europe for numerous public companies. Simek was recently President of a San Diego-based public medical electronics manufacturing company where he facilitated its turnaround and funding. Simek's corporate background includes over thirty years of management experience with major multinational companies in the medical, energy, electronics and aerospace industries. He has held key operational and management positions with several major multinational medical companies such as Baxter and Johnson & Johnson. Simek has facilitated raising capital in a number of public, private and start-up ventures; has identified and established joint venture transatlantic manufacturing, trading company and joint licensing programs; plus established and implemented multi-million dollar project management and manufacturing expansion programs. He has a B.S. from Illinois Institute of Technology and received his M.B.A. summa cum laude from Pepperdine University. Acquisiton Plan Although committed to its core manufacturing business in China, Rocky Mountain Ginseng, Inc. intends to capitalize on its expertise in the nutritional supplement arena, focusing on acquisitions and internet start-up opportunities in this industry. The company has been approached by numerous high-caliber acquisition candidates and is in the process of performing the appropriate due diligence to determine the course of action most advantageous to enhance shareholder value. ''Mr. Simek brings a unique blend of financial management and specialized business development strategies to the Rocky Mountain Ginseng Inc. team,'' stated Robert Bell, President, Rocky Mountain Ginseng, Inc. ''His input and knowledge will be of extreme value to the company. As we move forward with the acquisition and growth plan, I look forward to working closely with Jerry as a core member of our management team,'' concluded Mr. Bell. Mr. Simek stated, ''The recent success of VitaminShoppe.Com (Nasdaq:VSHP - news), PlanetRX.Com (Nasdaq:PLRX - news), and Drugstore.com (Nasdaq:DSCM - news) has further established our desire to enter the nutritional supplement internet arena. The supplement business here in the U.S. is experiencing tremendous growth both in the brick and motor model and on the internet. The expertise of Rocky Mountain Ginseng, Inc. in this arena has attracted some extremely promising potential acquisition candidates that will hopefully allow Rocky Mountain Ginseng, Inc. to rapidly bring to market lucrative business opportunities.'' About Rocky Mountain Ginseng, Inc. Rocky Mountain Ginseng, Inc.'s head office is located in British Columbia, Canada. The company exports American ginseng to China as well as processing America ginseng products in China. Rocky Mountain Ginseng, Inc. holds exclusive world processing and distribution rights to several innovative value added ginseng products developed in North America. Rocky Mountain Ginseng, Inc. purchased Fuzhou Fujian Drug Company, located in China, in February 1999. This acquisition included all necessary drug and hygiene licenses allowing the company to import, export, manufacture and distribute ginseng products in all provinces of China. The company has completed the construction of its new office and manufacturing facility in the city of Fuzhou and is currently producing traditional ginseng products for the Chinese Market. The Chinese factory employs 27 people in processing, sales, accounting and management. Rocky Mountain (Fuzhou) Drug Co. Ltd. is the first wholly owned American company in the Fujian province. This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Act of 1995. Expression of future goals and similar expressions reflecting something other than historical fact involve risks and uncertainties. The actual results the company achieves may differ materially from any forward-looking statements due to such risks and uncertainties. -------------------------------------------------------------------------------- Contact: Rocky Mountain Ginseng, Inc.